James V Leonard1, Suresh Vijayaraghavan, John H Walter. 1. Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, 30, Guilford Street, WC1N 1EH, London, UK. J.Leonard@ich.ucl.ac.uk
Abstract
UNLABELLED: The outcome of the severe variants of propionic and methylmalonic acidaemia is not good. Patients with these disorders have increased concentrations of propionylcarnitine and using tandem mass spectrometry to detect this compound, it is possible to screen in the newborn period. Various criteria have been used to identify the patients but only a small number of patients have been diagnosed so far and some have been missed. Furthermore many will have already presented before the result of the screening test is available. CONCLUSION: It is not yet clear whether the outcome is better for those identified in screening programmes.
UNLABELLED: The outcome of the severe variants of propionic and methylmalonic acidaemia is not good. Patients with these disorders have increased concentrations of propionylcarnitine and using tandem mass spectrometry to detect this compound, it is possible to screen in the newborn period. Various criteria have been used to identify the patients but only a small number of patients have been diagnosed so far and some have been missed. Furthermore many will have already presented before the result of the screening test is available. CONCLUSION: It is not yet clear whether the outcome is better for those identified in screening programmes.
Authors: L C Sniderman; M Lambert; R Giguère; C Auray-Blais; B Lemieux; R Laframboise; D S Rosenblatt; E P Treacy Journal: J Pediatr Date: 1999-06 Impact factor: 4.406
Authors: T H Zytkovicz; E F Fitzgerald; D Marsden; C A Larson; V E Shih; D M Johnson; A W Strauss; A M Comeau; R B Eaton; G F Grady Journal: Clin Chem Date: 2001-11 Impact factor: 8.327
Authors: S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier Journal: J Pediatr Date: 1994-12 Impact factor: 4.406
Authors: Stefan Kölker; Angeles Garcia-Cazorla; Angeles Garcia Cazorla; Vassili Valayannopoulos; Allan M Lund; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Persephone Augoustides-Savvopoulou; Lise Aksglaede; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Veronika Dvorakova; Francesca Furlan; Florian Gleich; Wanda Gradowska; Stephanie Grünewald; Anil Jalan; Johannes Häberle; Gisela Haege; Robin Lachmann; Alexander Laemmle; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Hélène Ogier de Baulny; Carlos Ortez; Luis Peña-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Christian Staufner; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Peter Burgard Journal: J Inherit Metab Dis Date: 2015-04-15 Impact factor: 4.982
Authors: James D Weisfeld-Adams; Mark A Morrissey; Brian M Kirmse; Bobbie R Salveson; Melissa P Wasserstein; Peter J McGuire; Sherlykutty Sunny; Jessica L Cohen-Pfeffer; Chunli Yu; Michele Caggana; George A Diaz Journal: Mol Genet Metab Date: 2009-09-27 Impact factor: 4.797
Authors: B Merinero; B Pérez; C Pérez-Cerdá; A Rincón; L R Desviat; M A Martínez; P Ruiz Sala; M J García; L Aldamiz-Echevarría; J Campos; V Cornejo; M Del Toro; A Mahfoud; M Martínez-Pardo; R Parini; C Pedrón; L Peña-Quintana; M Pérez; M Pourfarzam; M Ugarte Journal: J Inherit Metab Dis Date: 2007-10-22 Impact factor: 4.982
Authors: F Hörster; S F Garbade; T Zwickler; H I Aydin; O A Bodamer; A B Burlina; A M Das; J B C De Klerk; C Dionisi-Vici; S Geb; G Gökcay; N Guffon; E M Maier; E Morava; J H Walter; B Schwahn; F A Wijburg; M Lindner; S Grünewald; M R Baumgartner; S Kölker Journal: J Inherit Metab Dis Date: 2009-07-31 Impact factor: 4.982